8-K: Current report filing
Published on January 15, 2008
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 11,
2008
OPKO
Health, Inc.
(Exact
Name of Registrant as Specified in Charter)
|
|
|
|
|
|
|
Delaware
|
|
000-26648
|
|
75-2402409
|
|
(State
or other
jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
4400
Biscayne Blvd
Suite 1180
Miami,
Florida 33137
(Address
of Principal Executive Offices)
Registrant’s
telephone number, including area code: (305) 575-4138
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
o
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
|
Termination
of a Material Definitive
Agreement
|
||
On
January 11, 2008, OPKO Health, Inc. (the “Company”) repaid in full all
outstanding amounts and terminated all of the Company’s commitments under its
$4.0 million term loan with Horizon Financial Funding Company, LLC (the “Loan
Agreement”), which
was
being paid monthly since August 2007 and was to be paid in full by August 2008.
The
total
amount repaid by the Company in satisfaction of its obligations under the Loan
Agreement was $2.1 million. The Company realized a net savings by avoiding
future interest charges over the remaining term of the obligation, including
an
immaterial early termination penalty incurred in connection with terminating
the
Loan Agreement.
|
ITEM
9.01.
|
Financial
Statements and Exhibits.
|
|
|
(a)
|
Not
Applicable
|
|
(b)
|
Not
Applicable
|
|
(c)
|
Not
Applicable
|
|
(d)
|
None
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
||||
|
|
OPKO
Health, Inc.
|
||||
|
|
By
/s/ Adam Logal
|
||||
|
|
Name: Adam
Logal
|
||||
|
|
Title:
Executive
Director of Finance, Chief
Accounting
Officer, Treasurer
|
||||
|
|
|||||
Date
January 15, 2007